Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Zechmeister-Koss I. Zostavax zur Pravention von herpes zoster und postherpetischer neuralgie. Deutsche kurzfassung zum gleichnamigen EUnetHTA Bericht. [Zostavax for the prevention of herpes zoster and postherpetic neuralagia. Pilot assessment using the draft HTA core model for rapid relative effectiveness assessment. Pilot-ID: WP-SA-1] Vienna: Ludwig Boltzmann Institut fuer Health Technology Assessment (LBIHTA). Decision Support Document 73. 2013 Indexing Status Subject indexing assigned by CRD MeSH Herpes Zoster; Herpes Zoster Vaccines; Neuralgia, Postherpetic Country of organisation Austria English summary There is no English language summary available. Address for correspondence Ludwig Boltzmann Institute fuer Health Technology Assessment (LBI-HTA), Garnisongasse 7 rechte Stiege Mezzanin (Top 20), 1090 Vienna, Austria. Tel: +43 1 236 8119 - 0 Fax: +43 1 236 8119 - 99 AccessionNumber 32013000929 Date abstract record published 23/01/2014 |